Background. The global crisis of bacterial resistance urges the scientific community to implement intervention programs in healthcare facilities to promote an appropriate use of antibiotics. However, the clinical benefits or the impact on resistance of these interventions has not been definitively proved.
The global increase of bacterial resistance over recent decades has been recognized by public health organizations as a priority threat that needs to be addressed urgently by the scientific community [1] . Infections caused by resistant bacteria produce increased morbidity and mortality rates, as well as higher healthcare costs [2] , and the inappropriate use of antimicrobial agents is probably the most important factor responsible for these increases [3] . In this setting, healthcare centers have been encouraged to implement antimicrobial stewardship programs (ASPs) to improve antibiotic misuse and fight back against bacterial resistance [4] .
Evidence supporting the efficacy of ASPs is still incomplete, and recent meta-analysis has shown that up to 80% of reviewed studies lacked a minimum methodological quality required to obtain reliable and reproducible conclusions on the clinical impact of ASPs [5] . Although many of these programs have proved effective in reducing antibiotic consumption and improving the quality of prescriptions, there is still a lack of evidence supporting clear clinical benefits (ie, reduction in mortality rate related to infections) [5, 6] . The question regarding which indicators are best to assess the clinical impact of ASPs also remains unanswered [7] .
Data on the real impact of these programs on bacterial resistance are also incomplete. Although antibiotic pressure is a well-known risk factor for Candida spp. and multidrug-resistant (MDR) bacteria bloodstream infections (BSIs) [8] [9] [10] , the reverse effect-that is, reduced consumption of antibiotics bringing susceptible microorganisms back to a center or geographic area-has not been so well established. Hitherto, different ASPs have achieved reductions in specific mechanisms of resistance by restricting concrete antibiotic classes [11] [12] [13] , but a global improvement in bacterial ecology of healthcare centers has rarely been reported, and only the short-term impact has been described in most studies [5, 6] .
The Institutional Program for the Optimization of Antimicrobial Treatment (PRIOAM) is an educational ASP started at our hospital in January 2011, which resulted in a reduction in antimicrobial consumption within 1 year after its implementation [14] . We hypothesized that, if this reduction in antibiotic pressure was maintained throughout time, a significant decrease should also be observed in the incidence of hospital-acquired BSIs produced by MDR bacteria and Candida spp., as well as in associated mortality rates.
METHODS

Study Design
The study was an interrupted time-series (ITS) quasi-experimental before-after study, based on an ecological time-trend analysis, compliant with the ORION statement.
Setting
The program was performed at the University Hospital Virgen del Rocio (Seville, Spain), a tertiary-care teaching hospital with 1177 beds (including 72 intensive care unit [ICU] beds), and active solid-organ and hematopoietic stem-cell transplantation programs. No data from pediatric patients (134 beds, settled in a different building) were recorded for this study.
Study Period
The study period included 28 quarters between January 2009 and December 2015. PRIOAM was initiated in January 2011.
Intervention
The methods have been described elsewhere [14] . In brief, a multidisciplinary team of 10 counselors was set up, including infectious diseases experts from different departments of the hospital. They randomly chose 1 antibiotic prescription each week and held educational interviews (EIs) with the prescriber, reviewing the key aspects of antibiotic treatment of the case. The interview followed a structured questionnaire, and the approach was strictly educational; clinical charts were not reviewed and no changes in antibiotic treatment were required. Patient data remained anonymous.
Additional educative measures included (1) update, publication, and diffusion of local guidelines for the management of most frequent infectious syndromes [15] , which were also used as a reference to assess the quality of prescriptions during the interviews; (2) monthly educational meetings with the counselor team to reinforce the homogeneity of criteria and to encourage continuous learning regarding the main aspects of antibiotic use; (3) quarterly information regarding the profile of antibiotic use in every department; (4) yearly information on the incidence of bacterial resistance reported to all departments, and (5) yearly clinical sessions to analyze the specific results of the program in each unit, to outline the improvement strategies for the following year. The program received institutional support, and its objectives were included in the agreement signed annually by each department with the hospital management.
In November 2012 a parallel transmission control program was started at the ICU due to a long-term endemic of carbapenem-resistant Acinetobacter baumannii. This program included active surveillance of hygienic measures in the unit and weekly screening of asymptomatic carriers of MDR gram-negative bacilli for all patients admitted to the ICU. No other interventions were performed in the center during the study period.
Study Measures
Data on antibiotic ATC group J01 (antibacterials for systemic use) consumption were recorded quarterly. Defined daily doses (DDDs) per 1000 occupied bed days (OBDs) were calculated according to the Anatomical Therapeutical Chemical classification system [16] . We also analyzed the incidence density per 1000 OBDs of hospital-acquired BSIs produced by the 6 most frequent microorganisms (coagulase-negative Staphylococci excluded): Escherichia coli, Klebsiella pneumoniae, A. baumannii, Pseudomonas aeruginosa, Staphylococcus aureus and Candida spp. Every strain was classified as MDR or non-MDR according to the criteria described below. The impact on mortality rates was assessed as the all-cause crude death rate [17] (deaths per 1000 OBDs per quarter) on day +14 after the diagnosis of these episodes of BSI.
Microbiological Definitions
Hospital-acquired BSIs were defined as those diagnosed based on blood cultures obtained ≥48 hours after hospital admission, or <48 hours after admission in patients hospitalized during the previous 3 weeks. Recurrent isolation of the same microorganisms was considered to represent a unique episode of BSI unless the sample was obtained 1 month after the last positive blood culture. The MDR categorization was applied for extended-spectrum β-lactamases (ESBLs), derepressed AmpC β-lactamases or carbapenemase-producing Enterobacteriaceae, all isolates of methicillin-resistant S. aureus and Candida spp., and all P. aeruginosa and A. baumannii strains fulfilling the German Society for Hygiene and Microbiology criteria for MDR organisms [18, 19] . The ESBL and methicillin-resistant S. aureus criteria followed the European Committee on Antimicrobial Susceptibility Testing (EUCAST) recommendations [20, 21] .
Statistical Analysis
ITS regression analysis was performed for each variable according to the Cochrane Effective Practice and Organization Care method [22] , to compare time trends before and after the intervention. Two standardized effect sizes were estimated: a change in level (difference between the observed outcome at the first time point of the intervention and that predicted by the preintervention trend) and a change in trend (difference between pre-and postintervention slopes) after the intervention. Differences were considered statistically significant at P < .05 (2-tailed tests). Statistical analyses were performed using IBM SPSS Statistics software, version 19.0.
To assess the robustness of the findings from the ITS analysis, we also performed a joinpoint regression analysis [23] of each dependent variable as a sensitivity analysis. The aim was to identify any statistically significant change occurring in the linear slope of the trend for each variable and assess mathematically whether it occurred over the same time period as the intervention. We used the joinpoint regression program [24] to run the calculations.
RESULTS
Educational Interviews
A total of 3176 EIs were performed with prescribers from all clinical units; 1206 EIs were held in the first year, followed by an average of 500 per year. The proportion of prescribers interviewed the first year was 66.3% of the 585 prescribing physicians, followed by 49.7% per year. The average number of EIs was 3.1 EIs per prescriber the first year, followed by 2.2 EIs per prescriber per year. The average time required for each interview was 10 minutes. In the first quarter after the program implementation up to 53% of antibiotic prescriptions evaluated were considered inappropriate, improving to 39% by the end of the study period (χ 2 test; P < .01). Of 559 prescribers who completed an anonymous satisfaction survey after the EI, 97.7% evaluated it positively.
Antibiotic Consumption
The implementation of PRIOAM was followed by a significant decrease in antibiotic consumption, maintained during the following years. This reduction was observed for all classes of antibiotics (data not shown). The median consumption dropped from 1008 (interquartile range [IQR], 980-1078) to 774 (750-787) DDDs per1000 OBDs from the first to the last year. Figure 1 shows the time-trend analysis, with a significant change in level after the ninth trimester of −216. period, 5 years later. Incidence densities per quarter for each specific microorganism were also recorded. Conversely, the incidence density of hospital-acquired BSIs produced by non-MDR strains of the same microorganisms under study did not change during the intervention period (slope −0.004; 95% CI, −.045 to .037; P = .85) (Figure 3 ).
Impact on Mortality Rates for Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream Infections
The all-cause 14-day crude death rate for hospital-acquired candidemia and MDR BSIs was reduced parallel to its incidence. A significant change was proved in the mortality trends between the preintervention period (increasing trend of 0.011 deaths per 1000 OBDs per quarter; 95% CI, .005 to .017; P < .001) and the postintervention period (change in slope, −0.015 deaths per 1000 OBDs per quarter; −.021 to −.008; P < .001) (Figure 4 ). This change occurred 3 months after the PRIOAM implementation, with a level reduction of −0.045 (95% CI, −.087 to −.004; P < .01) and an estimated relative effect of −27.9% compared with the expected mortality rate according to the preintervention trend. The all-cause 14-day crude death rate for hospital-acquired BSIs produced by any microorganism (either MDR or susceptible) also decreased after the intervention ( Figure 5 ), reversing from a preintervention increasing trend (0.019; 95% CI, −.005 to .034) to a decreasing trend after the implementation of the program (change in slope −0.025; −.040 to −.009; P < .05). 
Potential Changes in Healthcare During the Study Period
To assess whether this reduction in the incidence of hospital-acquired candidemia and MDR BSIs could have been caused by other changes in the hospital activity, we also monitored 8 complexity indicators ( Table 1 ). All of them increased every year throughout the study period.
DISCUSSION
The results of our study prove the long-term impact of a novel educational ASP on antibiotic use and in-hospital bacterial resistance and mortality rate related to nosocomial BSIs, confirming the hypothesis that reducing antibiotic pressure can reduce the incidence of hospital-acquired MDR BSIs. To the best of our knowledge, this is the first education-based ASP proving such benefit.
Up to 50% of antimicrobial treatments prescribed at hospitals are considered inappropriate [25] , and this affects patients attended by all kinds of specialists. This situation is probably linked to insufficient training of clinicians in the diagnosis and treatment of the infectious diseases, as the amount of knowledge produced in this area has increased exponentially in the last decade [26] . For this reason, we believe the answer to this problem has to be essentially educational.
We previously reported a significant reduction in antibiotic consumption during the first year after PRIOAM was implemented [14] . Five years after initiation of the program, our results show how sustained educational interventions can achieve a longstanding benefit on antimicrobial pressure. This point seems especially relevant, because the effect of most ASPs interventions usually fades over time when discontinued [27] , with very few studies reporting results beyond 24 months [5] .
The sustained reduction of the use of all-class antibiotics prompted a global reduction in bacterial resistance over the months following the intervention. Different authors have reported successful interventions targeted toward certain classes of antibiotics, which have proved rapid and effective in reducing their consumption, and eventually the specific mechanisms of resistance related to these antimicrobials [11, 28, 29] . However, this approach may lead to compensatory consumption of alternative antimicrobials (the "squeezing balloon" phenomenon), which may also entail even worse consequences on bacterial resistance [12, 13, 30] .
The evidence supporting clinical benefits of ASPs is also insufficient. Although most ASPs have reduced the consumption of antibiotics, previous interventions have only shown the absence of deleterious effects of this reduction on mortality rates [5, 6] . In our study the crude death rate from hospital-acquired MDR BSIs decreased during the intervention, likely driven by the lower incidence of these infections associated with reduced use of antimicrobials. However, we also observed a reduction in the mortality rate due to non-MDR BSIs, even though the incidence of non-MDR BSIs remained unchanged during the intervention period. This improvement in outcomes among patients with non-MDR BSIs may resulted from improved management throughout our educational antimicrobial stewardship intervention.
In our opinion, the interest of our intervention relies not only on its efficacy but also in its methods. Many different interventions have been published so far, and no consensus exists on which may be more effective [5, 6] . Educational interventions have usually played a supplementary role in ASPs, and many authors have doubted the effect of adding educational measures to these programs, considering them dispensable [4, 5, 31] . Our results prove that educational interventions can be successful when based on active learning targeted toward real clinical problems of interest to specialists of all departments.
It has also been a matter of debate whether persuasive interventions are as effective as restrictions [5] . Restrictive measures have proved rapidly effective in reducing the use of specific antibiotics and the incidence of resistant bacteria linked to these antibiotics and thus might be indispensable in certain scenarios, such as epidemic outbreaks [32] . However, mandatory interruptions of antimicrobial treatments might be rejected by prescribers, who may feel that their autonomy is being interfered with [33, 34] . Moreover, restrictions on specific antibiotic agents may increase the use of other antibiotics with unintended consequences, as explained above [12, 13, 30] . Other effective persuasive measures can also be found in the literature, usually based on the review of clinical charts followed by noncompulsory recommendations on antimicrobial treatments [5, 11, 35] , but these interventions can be considerably time consuming and must be restricted to certain antibiotics or departments.
The aim of our program was not to change individual prescriptions but to teach prescribers to make better use of antibiotics for future patients. Indeed, the number of treatments reviewed by the PRIOAM team was relatively low compared with the number of all treatments prescribed in the hospital throughout the study period. The repetition of basic short messages to the prescribers proved effective in changing the way antibiotics were used in the hospital. In this sense, our program achieved results that were at least as effective as restrictive or persuasive measures hitherto published [5, 6] , with a feasible workload and a higher level of acceptance among the prescribers.
The results of PRIOAM attracted the attention of the Regional Ministry of Health of Andalusia, which prompted the Institutional Program for the Prevention and Control of Healthcare Associated Infections and Appropriate Use of Antimicrobials (PIRASOA) program in 2014, a comprehensive ASP based on the methods of our intervention, in public hospitals and primary care for a population of 8.4 million inhabitants [36] . Choosing an appropriate method to analyze ecological studies is essential, because unnoticed factors might be responsible for the changes observed. Two-group comparison tests have been strongly discouraged owing to their high susceptibility to different biases [37] even though many publications still support their results on bivariate analysis [38, 39] . The ITS method is the most robust for assessing time trends, and its use should be preferential to measure the impact of most ASPs [37] , as we did. Moreover, to avoid any possible ecological bias, we analyzed in detail the activity of the hospital and the microbiology department during the study period, and no confounding factors were detected. Besides, no additional interventions targeting antibiotic use were performed in the center during this period. Thus, it seems clear that the reduction in the antibiotic consumption is attributable to our intervention. Regarding the decrease in MDR BSIs, it is important to analyze the potential role of parallel transmission control measures. The active surveillance program started in the ICU in November 2012 undoubtedly had an important impact on the incidence of A. baumannii infections in this unit. This is why we decided to perform the joinpoint regression analysis in addition to the ITS analysis, to determine mathematically (not subjectively) the inflection point in the time trend. This analysis established that the point of inflection in the incidence of MDR BSIs preceded this surveillance program for >1 year. Furthermore, this reduction was observed at the hospital level (not only in the ICU where this initiative was exclusively performed) and also affected the incidence of MDR microorganisms that do not require patient isolation measures according to our local policies (eg, Candida spp. or ESBL-producing E. coli), making the participation of the surveillance program unlikely at this point. Finally, the reduction in hospital-acquired MDR BSIs was not accompanied by a decrease in nosocomial BSIs produced by susceptible microorganisms. Again, these data support the idea that the reduction of antibiotic pressure was the most likely cause of this change and no other factors (eg, improvements in general prophylactic or hygienic measures), which should have equally affected both resistant and susceptible microorganisms.
In conclusion, the results of this study show that the decrease and better use of antibiotics achieved by our ASP had a sustained ecological and clinical impact, reducing the incidence and mortality rate of hospital-acquired candidemia and MDR BSIs. In our opinion, the key to its success has been the pedagogical design and the institutional support, which gained the acceptance of the prescribers, the true protagonists of a sustainable change in the use of antibiotics.
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